Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression (SevereBD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03396601
Recruitment Status : Recruiting
First Posted : January 11, 2018
Last Update Posted : September 8, 2021
Target Health Inc.
Information provided by (Responsible Party):
NeuroRx, Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 31, 2022
Estimated Study Completion Date : April 30, 2022